DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 53 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,582,000 | -53.8% | 128,068 | -14.4% | 0.00% | -50.0% |
| Q2 2021 | $5,587,000 | +207.8% | 149,686 | +110.8% | 0.00% | +100.0% |
| Q1 2021 | $1,815,000 | +184.0% | 70,992 | +144.6% | 0.00% | – |
| Q4 2020 | $639,000 | -90.1% | 29,018 | -91.9% | 0.00% | -100.0% |
| Q3 2020 | $6,478,000 | +216.3% | 360,090 | +346.7% | 0.00% | +300.0% |
| Q2 2020 | $2,048,000 | +21.7% | 80,612 | -12.1% | 0.00% | -50.0% |
| Q1 2020 | $1,683,000 | +216.4% | 91,662 | +279.9% | 0.00% | +100.0% |
| Q4 2019 | $532,000 | +247.7% | 24,127 | +131.7% | 0.00% | – |
| Q1 2019 | $153,000 | +12.5% | 10,412 | -27.0% | 0.00% | – |
| Q1 2018 | $136,000 | +338.7% | 14,262 | +38.8% | 0.00% | – |
| Q2 2016 | $31,000 | – | 10,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |